ASCP 2025

ASCP 2025 is the official mobile companion for the 2025 ASCP Annual Meeting, designed to put program information and organizational details at your fingertips. The app gathers authoritative descriptions of the meeting’s scientific focus—neuropsychiatric drug development, the impact of diagnostic changes, and personalized interventions based on biomarkers or genetics—so clinicians, researchers, and industry representatives can quickly see why sessions matter. Users may download ASCP 2025 to review program direction, identify committee leadership and regulatory participation, and stay informed about the meeting’s priorities when planning attendance or collaboration.

Key Features

⭐ Official meeting program and agenda summaries reflecting the Program Committee's direction.

⭐ Detailed listings of committees, chairs, and review subcommittee leadership for transparent oversight.

⭐ Summaries of regulatory and research perspectives from FDA, EMA, NIH, and related agencies.

⭐ Industry Advisory Council updates and notes on pharmaceutical engagement and priorities.

Advantages

✅ Centralized access to the meeting’s program direction and committee structure.

✅ Useful for clinicians, researchers, and industry professionals tracking neuropsychiatric pharmacology developments.

✅ Clarifies regulatory and academic participation to inform collaboration and planning.

✅ Helps attendees prioritize sessions that focus on biomarkers, genetics, and personalized interventions.

Disadvantages

❎ Content is focused on the Annual Meeting and may have limited value outside that context.

❎ The app reflects the meeting’s agenda and leadership but does not replace direct engagement with organizers for detailed inquiries.

Development Team

Content presented in ASCP 2025 reflects guidance from a Program Committee chaired by Drs. Mark Rapaport and Tiffany Farchione, with a Review Subcommittee led by Drs. Manish Jha and Carlos Blanco. An Industry Advisory Council led by Drs. Ross Baker and Julie Adams helps ensure the meeting addresses the needs of pharmaceutical members, while representatives from the ASCP community, FDA, EMA, NIMH, NIDA, NIAAA and academic institutions contribute to the program direction.